Newormics at the 2019 International C. elegans Conference

Posted on June 20, 2019August 18, 2020 by adamlaing

Newormics is exhibiting at the 22nd International C. elegans Conference at UCLA, Los Angeles from 20th June – 24th June. Come and meet the team here at our booth.

Newormics selected for the NIH I-Corps

Posted on June 18, 2019December 11, 2019 by adamlaing

Newormics was selected for the NIH I-Corps April-June 2019 cohort. Over the course of the I-Corps program, the team had conversations with over 100 stakeholders in the field. This helped the company gather vital market research to understand the needs and pain points of potential customers, and improve Newormics product lines The program finale was Read more about Newormics selected for the NIH I-Corps[…]

Newormics awarded SBIR Phase I grant from the NIMH

Posted on October 9, 2018November 9, 2019 by adamlaing

Newormics was awarded an SBIR Phase I grant from the National Institute of Mental Health (NIMH) for the project “A multi-well plate format microfluidic immobilization chip for high-content imaging of whole animals”. Advancements in precise genetic manipulation have helped biologists to identify new drug-targets and in vivo disease mechanisms using small animal models, such as Read more about Newormics awarded SBIR Phase I grant from the NIMH[…]